Q Laboratories Blog Bactericidal Considerations to the FDA Briefing Document

Bactericidal Considerations to the FDA Briefing Document As you may or may not have heard, the FDA has released a Briefing Document in March of 2020 that proposes an alternative organism panel from the Tentative Final Monograph (TFM) for consumer and healthcare antiseptics. Amongst growing interest from our clients on this topic, we have authored ... Read moreThe post Bactericidal Considerations to the FDA Briefing Document appeared first on Welcome to Q Laboratories.